Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis

Figure 5

Analysis of tumor cell migration by the Transwell chamber assay. To evaluate the migratory potential, drug treated versus non-treated (control) tumor cells were seeded in the upper chamber and 10% serum as the chemoattractant was placed in the lower well. The upper chamber has been coated with collagen. Cells which migrated to the lower surface of the membrane were stained using hematoxylin and counted. Controls were set to 100%. * = significant different to controls. # = significant different to single drug treatment.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us